Patent Baristas

Groklaw, which advertises itself as “When you want to know more but don’t know where to look” has put together an exhaustive list of links in a Patent Resource Page. Frankly, I was starting to get carpal tunnel syndrome just scrolling through the list. While heavy on software patent and Open Source issues, it is […]

The House Subcommittee on Intellectual Property circulated a discussion draft a Patent Reform Bill. Since it’s just a draft, it’s not worth over-analyzing at this point but it is interesting to get a glimpse at the topics that may be subject to amendment. The proposed legislation includes changes to: Creating a post-grant opposition procedures Willfulness […]

Best Barista, Troels Overdal Poulsen of Copenhagen carried 12 liters of fresh, whole milk from his native Denmark to Seattle in beating five other finalists winning the sixth annual World Barista Championship. The contestants competed in an against-the-clock competition that required each barista to make four espressos, four cappuccinos and four “signature” drinks in just […]

As Benjamin Franklin wrote in 1789, “Our new Constitution is now established, and has an appearance that promises permanency; but in this world nothing can be said to be certain, except death and taxes.” It’s Tax Day and all the little people have to pay their taxes by today to the Internal Revenue Service. Well, […]

The premier issue of Blawg Review was hosted Monday, April 11th, at Evan Schaeffer’s Notes from the (Legal) Underground with 31 noteworthy posts from this past week in the blawgosphere. Presented as “a group of law bloggers who are committed to making the best of the blawgosphere more easily accessible and enjoyable to read,” Blawg […]

Barr Pharmaceuticals Inc. announced that it dropped its lawsuit against the Food and Drug Administration (FDA) over exclusive marketing rights to a generic version of the Allegra allergy drug made by France’s Sanofi-Aventis. In February, Barr sued the FDA to challenge its decision to make the company share a 6-month exclusive selling period. The company […]

TheDeal.com has a nice article outlining the issues that can arise in a large pharma mega-merger such as between French pharmaceuticals company Aventis SA takeover by Gallic rival Sanofi-Synthélabo SA, in a €53.3 billion ($69.1 billion) after Paris intervened to fend off a Swiss attempt. The results are still mixed. Sanofi-Aventis SA, the world’s No. […]

The U.S. Federal Circuit voted en banc to vacate a holding from a panel opinion with regard to the issue of experimental use, and the panel (J. Rader) has issued a new decision regarding a previous holding that the paroxetine hydrochloride anhydrate product produced by Apotex Corp. infringes Smithkline’s U.S. Patent No. 4,721,723 covering crystalline […]